Literature DB >> 485575

Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.

J R Walker, D W James, M J Smith.   

Abstract

The migration of peripheral polymorphonuclear leucocytes (PMNs) of patients with rheumatoid arthritis has been studied both in vivo and in vitro. A significant reduction in the accumulation of PMNs in skin chambers in patients with rheumatoid arthritis compared to controls was observed but no defect in cell movement was detected when the isolated PMNs from the patients were exposed to activated control plasma. However, when PMNs from the control group were tested against activated plasma from patients with rheumatoid arthritis there was a significant decrease in their chemotactic response. It is proposed that there is a humoral defect in the plasma of the patients.

Entities:  

Mesh:

Year:  1979        PMID: 485575      PMCID: PMC1000437          DOI: 10.1136/ard.38.3.215

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Plasma and cell-derived inhibitors of human neutrophil chemotaxis.

Authors:  E J Goetzl
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

2.  Effects of a human plasma fraction on the release of chemotactic factors and anaphylatoxin from complement.

Authors:  J R Walker; J K Badcock; A W Ford-Hutchinson; M J Smith; F J Billimoria
Journal:  J Pharm Pharmacol       Date:  1975-10       Impact factor: 3.765

3.  Defective neutrophil migration in sarcoidosis.

Authors:  R W Gange; M M Black; P Carrington; R McKerron
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

4.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

5.  Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus.

Authors:  E J Goetzl
Journal:  Ann Rheum Dis       Date:  1976-12       Impact factor: 19.103

6.  Factors relating to circulating immune complexes in rheumatoid arthirits.

Authors:  P J Roberts-Thomson; B L Hazleman; I G Barnett; I C MacLennan; A G Mowat
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

7.  Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome.

Authors:  E R Hurd; M Andreis; M Ziff
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

8.  Leukotactic dystunction in sarcoidosis.

Authors:  E G Maderazo; P A Ward; C L Woronick; J Kubik; A C DeGraff
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

Review 9.  Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.

Authors:  P G Quie; K L Cates
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

10.  Regulatory dysfunction in leukotaxis.

Authors:  P A Ward; K J Johnson; D L Kreutzer
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

View more
  8 in total

1.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect.

Authors:  E C Moore; F Cohen; S D Douglas; V Gutta
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.

Authors:  J Elmgreen; T M Hansen
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

3.  Leucocyte function in patients with rheumatoid arthritis: quantitative in-vivo leucocyte mobilisation and in-vitro functions of blood and exudate leucocytes.

Authors:  J H Wandall
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

4.  Effects of tenoxicam on neutrophil chemotaxis in rheumatoid arthritis and healthy controls.

Authors:  Z Hascelik; G Hascelik; R Celiker; M Ozalp
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome.

Authors:  G B Howe; J N Fordham; K A Brown; H L Currey
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  An inhibitor of leucocyte movement in the plasma of patients with rheumatoid arthritis.

Authors:  J R Walker; M J Smith
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

7.  Biological activities of leukotriene B4.

Authors:  M J Smith
Journal:  Agents Actions       Date:  1981-12

8.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.